Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading on Nasdaq under the ticker PWUP, filed an 8-K current report with the Securities and Exchange Commission on June 22, 2026, bearing accession number 0001493152-26-029599. The company operates within the biopharma and life sciences sector and is associated with a SPAC vehicle that has been active in the public markets. The 8-K filing reflects the company's ongoing disclosure obligations as it moves through its current operational phase. Biopharma-focused SPAC activity continues to draw attention from institutional and retail investors alike. Sign up for full data, filings, and analytics on SpacDesk to track PWUP and every active SPAC in the market.